The initial assessment of acid-base status is usually based on the measurement of total CO 2 concentration ([TCO 2 ]) in venous blood, a surrogate for . Previously, we posited that the reference limits of serum [TCO 2 ] in current use are too wide. Based on studies on the acid-base composition of normal subjects, we suggested that the reference limits of serum [TCO 2 ] at sea level be set at 23-30 mEq/L. To validate this proposal, we queried the University of California at Los Angeles (UCLA's) Integrated Clinical and Research Data Repository, a database containing information on 4.5 million patients seen at UCLA from 2006 to the present. Criteria for inclusion included adults (18-40 years of age), who were free of disorders that could affect acid-base balance, were not taking medications that could affect acid-base balance, and were seen for a routine medical examination or immunization in the outpatient setting. The number of individuals who met the inclusion criteria (52% female and 48% male) was 28,480, with a mean age of 28.9 ± 5.1 years. The mean serum [TCO 2 ] level was slightly higher in males than females, 26.6 ± 2.16 mEq/L vs. 25.0 ± 2.11 mEq/L (p < 0.05). Ninety-one percent of patient values were within the proposed 23-30 mEq/L range and 61.7% were within the 24-27 mEq/L range. These findings validate our proposal that the reference range of serum [TCO 2 ] in venous blood at sea level be narrowed to 23-30 mEq/L. Subjects with serum [TCO 2 ] outside this range might require assessment with a venous blood gas to exclude the presence of clinically important acid-base disorders.
Introduction
Disorders of acid-base balance can adversely affect the clinical outcome and can also point to the presence of an underlying disease [1] . Therefore, it is important to assess whether the acid-base status of a patient is nor-DOI: 10.1159/000489965 mal or abnormal, and if abnormal, to define the precise nature of the acid-base disorder(s) present. Such assessment requires the reliable determination of pH, PCO 2 , and [HCO 3 -] in arterial or venous blood. However, in clinical practice, the determination of these acid-base parameters is not routinely obtained. Rather, serum total CO 2 concentration ([TCO 2 ]) in venous blood, a surrogate for [HCO 3 -], is measured and used as a screening tool for acid-base abnormalities [2] . The underlying rationale is that both metabolic and respiratory disorders (the latter by virtue of the secondary responses of [HCO 3 -] to changes in PCO 2 ) are associated with abnormalities in [HCO 3 -] [2, 3] . Obviously, the optimal use of serum [TCO 2 ] as a screening tool for acid-base disorders rests with a rigorous definition of its reference range.
We have long been concerned about the inordinately wide limits of the reference range for serum [TCO 2 ] reported by clinical laboratories (commonly with a span of 10-13 mEq/L) and the associated risk that values residing within the lower or upper end of this expansive range might be masking the presence of a cardinal acid-base disorder. In a recent publication [4] , we first derived the expected reference range of serum [TCO 2 ] in venous blood in adults at sea level by analyzing carefully conducted studies on acid-base composition of normal subjects. We then compared this range to that reported by the clinical laboratories of 64 hospitals in the United States and 2 large commercial clinical laboratories, as well as the reference range endorsed by the American Association of Clinical Chemistry and that listed in the Tietz Textbook of Clinical Chemistry and Molecular Diagnostics [5] , the major clinical chemistry textbook.
The expected reference range of serum [TCO 2 ] in venous blood formulated by us was 23-30 mEq/L (a span of 8 mEq/L) and was closely approximated by that cited by the American Association of Clinical Chemistry [6] and the Tietz Textbook of Clinical Chemistry and Molecular Diagnostics [5] (23-29 mEq/L, a span of 7 mEq/L). In sharp contrast, there was marked variability in the reference range among clinical laboratories, with values at the lower limit varying from 18 mEq/L to 25 mEq/L, and values at the upper limit varying from 26 mEq/L to 35 mEq/L.
We argued that the reference range for serum [TCO 2 ] reported by many clinical laboratories was too wide and encompasses values both at the lower and the upper end that could be consistent with a cardinal acid-base disorder. We therefore suggested that these limits be reconsidered and that the reference range of serum [TCO 2 ] be narrowed to 23-30 mEq/L. Inclusion criteria were as follows: (1) Adults 18-40 years of age seen as outpatients, whose encounter information indicated they were seen for a general adult medical examination without abnormal findings, a routine general medical examination at a healthcare facility, or for routine immunization. (2) Absence of kidney disease (chronic kidney disease, acute kidney injury, or renal tubular acidosis), pulmonary disease, heart failure, liver disease, cancer (other than localized disease), diabetes mellitus, gastrointestinal disease, vomiting, diarrhea, or pregnancy, each on the basis of absence of the corresponding ICD-9 or ICD-10 codes. (3) Patients should not be taking medications that could affect acid-base balance, such as diuretics, base-containing substances (including salts of bicarbonate, citrate, acetate, or carbonate), converting enzyme inhibitors or angiotensin receptor blockers, carbonic anhydrase inhibitors, or steroids. Only the initial value for serum [TCO 2 ] was included for each eligible patient. This investigation was approved by the UCLA Committee on Human Research.
Statistics
Continuous variables are presented as mean ± SD and categorical variables as frequency count (percentage). Differences between groups were determined using Student t test, chi-square analysis, and quantile regression. p values < 0.05 were considered significant.
Results
In all, 28,480 individuals met the inclusion criteria (0.63% of the total individuals in the database). Of these, 12,570 patients were seen for a general adult medical ex- amination without abnormal findings, 15,592 were seen for a routine general medical examination at a healthcare facility, and 318 were seen for routine immunization.
The general characteristics of the analyzed patients are summarized in Table 1 . Fifty-two percent of the patients (14,766) were female and 48 % (13,714) were male. The mean age of the combined cohort was 28.9 ± 5.1 years, whereas the mean age of males was 29.1 ± 5.1 years and that of females was 28.7 ± 5.0 years (p < 0.05). The distribution of race is shown in Table 1 ; in 13,554 patients (48%), race was not reported.
The mean serum [TCO 2 ] of the combined cohort was 25.8 ± 2.28 mEq/L (Fig. 1 ) and the median value was 26 mEq/L; 91% of patient values laid within the proposed 23-30 mEq/L range (span of 8 mEq/L) and 61.7% were within the 24-27 mEq/L range (span of 4 mEq/L; Table 2 and Fig. 2) .
The mean serum [TCO 2 ] was slightly higher in males than females, 26.6 ± 2.16 mEq/L vs. 25.0 ± 2.11 mEq/L (p < 0.05; Fig. 1 
Discussion
On the basis of an analysis of carefully conducted studies on acid-base composition of normal subjects, we recently proposed that the reference range of serum [TCO 2 ] in venous blood at sea level be narrowed to 23-30 mEq/L [4] . The results of the present study provide strong validation of the proposed range in that 91% of the serum [TCO 2 ] of apparently healthy younger adults residing at sea level were within the 23-30 mEq/L limits ( Table 2 and Fig. 2 ). This finding is all the more remarkable, considering that serum [TCO 2 ] was measured utilizing routine procedures in different clinical laboratories in the UCLA system. In individuals residing above the sea level (particularly at altitudes greater 1,500 m or 4,196 feet), the prevailing chronic hypocapnia is expected to shift the reference range of serum [TCO 2 ] to the left. Reference ranges for these individuals should be established separately.
Our validation cohort, although large (28,480 individuals), was a fraction of the approximately 4.5 million patients contained in the UCLA xDR database (0.63%), as a result of the strict inclusion criteria used. As noted, we selected younger adults (18-40 years of age), who were free of diseases and conditions that could perturb acidbase status, were not taking medications that could affect acid-base balance and were seen for a routine medical examination or immunization in the outpatient setting. Indeed, the mean age of the combined cohort was 28.9 years. This relative youthfulness made it less likely 3 -] in premenopausal women is approximately 1 mEq/L lower than that in men [7] . This small difference has been attributed to the PaCO 2 of premenopausal women being lower by 2-4 mm Hg than that of normal men reflecting the centrally mediated effect of progesterone to stimulate alveolar ventilation. Serum [HCO 3 -] rises with the appearance of menopause and such increase is reversed by hormone replacement therapy that includes progesterone [8] . Expectedly, females (premenopausal) in our study had a slightly lower mean serum [TCO 2 ] than males (by 1.6 mEq/L; Fig. 1 ) and the distribution of their serum [TCO 2 ] values was shifted toward lower values (Table 2 and Fig. 2 ).
Only a small fraction of our combined cohort (9%) had serum [TCO 2 ] values residing outside the proposed 23-30 mEq/L range (Fig. 2) . Examining this issue in more detail, 3% of males but 11.3% of females had serum protein and grains and decreased intake of fruits and vegetables might be contributing to the serum [TCO 2 ] residing outside the lower end of the reference range [9] . Undiagnosed bowel disorders, diet-induced ketosis, mild diabetic ketoacidosis, renal tubular acidosis, and hyperventilation triggered by a number of causes (e.g., anxiety, the hyperventilation syndrome) are among the many potential etiologies of the low serum [TCO 2 ] values in our cohort. Because our data originate from an administrative database, we were unable to search for potential etiologies.
On the other hand, only 2.9% of males and 0. (Table 2) . Again, a limited number of individuals with values just outside the upper limit of the reference range are normal outliers, but many must harbor a cardinal acid-base disorder, namely, metabolic alkalosis or respiratory acidosis. Subjects ingesting primarily a vegetarian diet might also have values outside the upper end of the reference range. Undiagnosed disorders, such as surreptitious vomiting or diuretic use, Gitelman syndrome, and rare cases of hypoventilation (e.g., the obesity-hypoventilation syndrome) are among the potential etiologies of high serum [TCO 2 ] values in our cohort. The strength of this study is the inclusion of more than 28,000 individuals carefully selected from the approximately 4.5 million patients listed in the UCLA xDR database to ensure that only younger adults seen as outpatients and devoid of any conditions that could affect acidbase balance were eligible. However, the absence of these undesirable conditions was only based on the absence of the corresponding ICD-9 and ICD-10 codes assigned to the outpatient visit; obviously, the veracity of such assessment rests with the completeness of the patient's diagnoses described by the health professional. Strengthening the position that we actually analyzed apparently healthy younger adults is that the patients were seen for a general adult medical examination without abnormal findings, a routine general medical examination at a healthcare facility, or for routine immunization. Yet, we acknowledge that they differ from an unselected normal population in that they subjected themselves to an outpatient evaluation by a physician. An additional weakness of our study is that medications listed in the database might not have captured all medications taken by the patient as well as over-the-counter medications. Be that as it may, additional analyses of large cohorts of individuals, in which relevant conditions are rigorously controlled, are needed to confirm these findings.
In summary, the present study provides strong external validation of our recent proposal that the reference range of serum [TCO 2 ] in venous blood at sea level be narrowed to 23-30 mEq/L. As before, we recommend that subjects with verified serum [TCO 2 ] outside this range be considered for assessment with a venous blood gas to exclude the presence of clinically important acidbase disorders.
